NCT00034645View on ClinicalTrials.gov

Prophylaxis Trial in High Risk Allogenic Stem Cell Transplant Recipients With Graft vs. Host Disease

PHASE3CompletedINTERVENTIONAL
Enrollment

600

Participants

Timeline

Start Date

January 31, 1999

Primary Completion Date

February 28, 2003

Study Completion Date

February 28, 2003

Conditions
Mycoses
Interventions
DRUG

Posaconazole oral suspension

All Listed Sponsors
lead

Merck Sharp & Dohme LLC

INDUSTRY

NCT00034645 - Prophylaxis Trial in High Risk Allogenic Stem Cell Transplant Recipients With Graft vs. Host Disease | Biotech Hunter | Biotech Hunter